Digital Journal
Annovis Bio (NYSE: ANVS) Releases Significant Findings from Phase 3 Parkinson's Study
RELEASE Published July 2, 2024 InvestorBrandNetwork Annovis Bio (NYSE: ANVS) , a late-stage, clinical-drug platform company pioneering transformative therapies ...
4 days ago